What did @gabi.brandao actually say?
Honestly, this is a difficult video to fact-check because the transcript is largely incoherent. The auto-generated captions appear to have failed significantly, producing fragments like "farm-achising" and disconnected references to skin, masks, and family. The caption asks "Does pharmacy testosterone cause fewer side effects?" but the spoken content doesn't coherently answer that question.
What we can piece together: the creator seems to be comparing pharmaceutical-grade testosterone to some other source, possibly implying regulated pharmacy testosterone is safer or produces fewer adverse effects. There are references to personal experience and asking about "ingredients" and "supply." The video is tagged as TRT content and includes a discount code for a supplement brand, which shapes the commercial context significantly.
Because the transcript is unreliable, this fact-check will focus on the question posed in the caption itself, since that's the claim viewers are responding to.
Does the science back this up?
The short answer: pharmaceutical-grade testosterone is better characterized, not inherently safer. The side effect profile of testosterone therapy is tied to dose, ester, route of administration, and the individual's baseline health, not primarily to whether the product came from a pharmacy versus another source.
A 2018 review by Bhasin et al. in the New England Journal of Medicine confirmed that testosterone therapy, regardless of formulation source, carries consistent risks including erythrocytosis, suppression of endogenous testosterone production, potential cardiovascular effects, and acne. These are pharmacological effects of testosterone itself, not contaminants or quality issues.
That said, there is a real quality-control argument for regulated pharmacy products. Compounded testosterone preparations, for example, have shown variable potency in independent testing. A 2013 study published in the Journal of Clinical Endocrinology and Metabolism found meaningful concentration deviations in compounded hormone products. So "pharmacy testosterone" being more predictable in dose is a defensible point. Fewer side effects from the drug itself? That's a different, less supported claim.
What did they get wrong (or right)?
The caption framing is where the problem sits. Asking whether pharmacy testosterone gives "fewer side effects" implies that the source of the drug changes its pharmacological behavior. It largely does not. Testosterone acts on androgen receptors the same way whether the vial was filled at a regulated pharmacy or elsewhere. What changes with pharmaceutical-grade products is dosing accuracy and sterility assurance, which matter clinically but are not the same as reduced side effects.
If the creator's actual argument was about avoiding contaminated or mislabeled products, that's a reasonable harm-reduction point. Testosterone from unregulated sources can be underdosed, overdosed, or contaminated, which introduces unpredictable risks on top of testosterone's known effects.
The discount code for a supplement company embedded in a TRT discussion also deserves scrutiny. Viewers may conflate supplement products with pharmaceutical testosterone, which is a meaningful clinical distinction that the video does nothing to clarify.
What should you actually know?
Testosterone therapy, at any quality level, suppresses the hypothalamic-pituitary-gonadal axis. That means your body reduces or stops its own testosterone production during use. This happens with regulated pharmacy testosterone, compounded testosterone, and every other bioavailable form. It is not a side effect you can avoid by choosing a better pharmacy.
Clinically documented risks of testosterone therapy include increased red blood cell count (requiring monitoring), changes in lipid profiles, testicular atrophy, and potential effects on fertility. The Testosterone Trials, a coordinated set of studies published across multiple journals between 2016 and 2017, provided some of the most rigorous data available and showed that cardiovascular risk signals warrant careful monitoring in older men.
If you are considering TRT, the relevant questions are not about pharmacy branding. They are about whether you have a confirmed diagnosis of hypogonadism, what your baseline labs show, and whether a licensed clinician is supervising your care. A coupon code is not a substitute for that conversation.